InSphero Hires New Director of Global Marketing
News Jan 30, 2014
With Dr. Strube, InSphero won a technically skilled and very experienced life science professional to continue its remarkable growth over the past years. Previously, Dr. Strube has helped build outstanding marketing frameworks for successful companies such as Enzo Life Sciences, Inc. and Assay Designs, Inc. As a trained microbiologist with a Ph.D. in cancer biology, he also brings the necessary technical background to help InSphero educate and inform the life science community about the advantages of 3D-cell-based assays over conventional 2D monolayers.
"As a rapidly growing, global innovation driver in the field of 3D cell-culture, we have a lot to tell" explains Dr. Jan Lichtenberg, CEO and co-founder of InSphero. "With Dr. Strube joining us, we will be faster and more to the point in explaining InSphero's cutting-edge products and services to drug-discovery and drug-safety customers all over the world."
Excited to be part of the InSphero team, Dr. Strube commented, "The scientific and executive leadership at InSphero have established a technology, in-house expertise, and strategic partnerships that clearly distinguish InSphero within the 3D marketplace. I'm honored for the opportunity to help build the InSphero brand globally and to communicate the industry-transforming benefits of our technology to the scientific community."
Electron Microscope Detector Achieves Record ResolutionNews
Like driving at night and being able to read the license plate of an oncoming car without being blinded by the lights.READ MORE
Molecular Key for Delaying Multiple Sclerosis ProgressionNews
In work just published it was possible to identify a receptor known as P2X4 present in the microglial cells that increases their anti-inflammatory potential in order to reduce the damage in Multiple Sclerosis and, above all, encourage the body's own repair responses.READ MORE
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE